{
    "drug": "avrapritinib",
    "approval_history": [
      {
        "date": "2020-01-09",
        "region": "United States",
        "agency": "FDA",
        "indication": "Unresectable or metastatic GIST harboring a PDGFRA exon 18 mutation"
      },
      {
        "date": "2021-06-16",
        "region": "United States",
        "agency": "FDA",
        "indication": "Advanced systemic mastocytosis (SM)"
      },
      {
        "date": "2023-05-22",
        "region": "United States",
        "agency": "FDA",
        "indication": "Indolent systemic mastocytosis"
      },
      {
        "date": "2020-09",
        "region": "European Union",
        "agency": "EMA",
        "indication": "Gastrointestinal stromal tumor (GIST)"
      },
      {
        "date": "2021-03-30",
        "region": "China",
        "agency": "NMPA",
        "indication": "Unspecified"
      }
    ]
  }